Work

Rupture, invasion and inflammatory destruction of the intestinal barrier by Shigella, making sense of prokaryote–eukaryote cross-talks

Year: 2001
Type: review
Abstract: Bacillary dysentery is an acute inflammatory bowel disease caused by an infectious agent, the enteroinvasive genus Shigella, hence the name shigellosis. Shigellae have the capacity to invade the colonic and rectal epithelium in humans, thereby causing the acute mucosal inflammation that characterizes the disease. Shigellosis is endemic throughout the world, but 99% of the 150 million annual cases and almost all of the million deaths occur in the developing world, particularly in areas where personal and general hygiene are insufficient. Shigellosis is a disease of impoverished people which in about 70% of the cases affects children between the ages of 1 and 5 years [1]. There are four species of Shigella: S. dysenteriae, among which serotype 1 (shiga bacillus) accounts for brisk and deadly epidemics in the poorest populations, S. flexneri and S. sonnei which account for the endemic form of the disease, the latter being prevalent in the industrialized world, and S. boydii which is only observed in the Indian subcontinent. In view of increasing antibiotic resistance and persistence of the poor hygiene conditions that allow contamination, vaccination appears the most cost-effective approach in spite of tremendous difficulties in developing a new vaccine in this particular situation [2]. Shigella is a highly contagious microorganism since as few as 10–100 bacteria can cause the disease in adult volunteers. After oral contamination, bacteria pass through the stomach and the small intestine before reaching the colon where they invade the mucosa, initiating the acute destructive recto-colitis that causes the dysenteric symptoms: fever, intestinal cramps and emission of mucopurulent and bloody stools. The basis for organ specificity of shigellosis to the rectal and colonic mucosae is not understood. Shigella may express a colon-specific adhesive system, or the colonic and rectal mucosae may be more susceptible to developing acute inflammation in the presence of invasive shigellae. The disease remains essentially limited to the intestinal mucosa and septicemic dissemination is a rare event, except in malnourished children. The molecular and cellular effectors of innate immunity that eradicate the bacteria during the phase of primary infection and prevent systemic dissemination at the price of intestinal tissue destruction have yet to be fully identified and their mode of action characterized. Shigellosis can be seen as a loss of balance in the host mechanisms that regulate inflammation in the presence of an invading microorganism, emphasizing that in the elucidation of an infectious process, equal attention should be paid to the mechanisms of infection and the mechanisms of host response. A series of discoveries have recently allowed progress in our understanding of the molecular mechanisms by which Shigella disrupts, invades and destroys the intestinal barrier [3]. Understanding the molecular and cellular bases of these mechanisms is essential to develop innovative antipathogenicity molecules and vaccine candidates against this disease. All virulent isolates of Shigella carry a 220-kb plasmid which encodes the ‘invasive phenotype’ of this species. In cell assay systems, expression of this invasive phenotype depends on the cell population that is used as a target (Fig. 1). Differential expression of the Shigella invasive phenotype depending on the cellular target. In each case, the outcome of this interaction participates in the triggering and amplification of inflammation. In the presence of epithelial cells, invasive Shigella induce massive reorganization of the subcortical cytoskeletal network causing the formation of a macropinocytic vacuole, entry into the cells and intracellular growth after quick lysis of the endocytic vacuole. Escape into the cytoplasm is followed by an actin-dependent motility process which leads to bacterial passage into adjacent cells [4]. In addition, intracellular microorganisms program epithelial cells to become pro-inflammatory cells and to play a major role in elicitation of mucosal inflammation [5]. In the presence of lipopolysaccharide (LPS)-activated macrophages, invasive Shigella survive and grow, they quickly induce apoptosis and cause massive secretion of interleukin (IL)-1β [6] and IL-18, factors that are likely to play a central role in initiating inflammation. In the presence of polymorphonuclear leukocytes (PMN) invasive Shigella cause increased adherence and release of granular content, thereby adding to the severity of inflammation [7], although Shigella is unable to survive in those activated PMNs [8]. Although cellular approaches tend to provide an oversimplified (i.e. reductionist) view of the infectious process, it is likely that, in vivo, expression of the invasive phenotype of Shigella upon its various cellular targets, results in rupture, invasion and destruction of the mucosal barrier. In S. flexneri as well as in the other Shigella species, a large virulence plasmid contains most of the key genes required to express the invasive phenotype [9, 10]. After completion of the sequence and annotation of pWR100, the 214-kb plasmid of the S. flexneri 5a strain M90T [11], it appears that about one third of the sequences corresponds to various complete and incomplete insertion sequences that are likely to reflect the natural history of this plasmid’s construction. The coding sequences are scattered on the entire plasmid with one block of 30 kb showing a particularly dense pattern of genes, the ipa/mxi-spa locus that can be considered the central S. flexneri pathogenicity island (PAI). This PAI, which is shown in Fig. 2, is necessary and sufficient to cause entry of Shigella into epithelial cells and macrophage apoptotic death. Map of the plasmid-located Shigella‘pathogenicity island’ of 30 kb that is required for entry into epithelial cells and killing of macrophages. Based on available data, one can consider that this PAI primarily encodes a type III secreton, in other words a flagella-like structure able to deliver Shigella proteins straight from the bacterial cytoplasm into the cytoplasmic membrane of epithelial cells, or into their cytoplasm. At least five proteins encoded by the mxi operon assemble to form a structure that can be divided into three domains: a cytoplasmic bulb, a multidisc, transmembrane domain that spans the inner and outer membrane of the bacterium, forming a basal body-like structure, and a needle of 60 nm which is expected to deliver the effector proteins through a channel of 2–3 nm [12, 13]. This secretory apparatus, which is similar to the type III secreton of Salmonella[14], is activated upon contact with the cellular surface. There are about 20 candidate target proteins secreted through this secreton, upon contact of the bacterium with the epithelial cell surface. Five of them, IpaA–D and IpgD, are encoded by the 30-kb PAI. Others are encoded by genes scattered on the virulence plasmid. These genes share a low GC content of about 35% [11]. These proteins have no signal peptide but are likely to share common features on their N-termini which target them to the secreton. Some of these target proteins are associated in the bacterial cytoplasm to a dedicated chaperone which prevents their proteolytic degradation. There are two categories of proteins secreted through the type III secreton: IpaB, IpaC and IpaD are essential to the initial events of secretion. IpaB and IpaD form a complex which controls the flux of proteins through the type III secreton. It is likely to be the primary target of the signal inducing secretion upon contact of bacteria with eukaryotic cells. IpaB and IpaC then form a complex which inserts into the eukaryotic cell membrane to form a pore [12–15]. In the presence of an epithelial cell, this pore expresses a dual function: it induces the early events of actin polymerization via the C-terminal domain of IpaC [16] and it is also likely to allow the injection of several proteins into the cell cytoplasm. In the presence of a macrophage, IpaB causes apoptosis of the target cell. These properties are summarized in Fig. 3. IpaA and IpgD, like IpaB, C and D, are constitutively expressed at 37°C, regardless of the activity of the type III secreton. Deletion of their respective genes does not eliminate the entry capacity of the mutants, but induces significant attenuation, indicating that these genes have an effect on the maturation of the entry focus. The second category of proteins encompasses two subgroups. These proteins, of still unidentified function, correspond to putative additional targets for the type III secreton, such as members of the IpaH family, SopB and VirA. Their genes are transcriptionally induced upon activation of the secreton. This illustrates how far we are from having identified the function of many secreted proteins. In any event, the type III secreton and its target proteins can now be regarded as the major weapon that Shigella uses to enter into epithelial cells and also to alter the function of others such as phagocytes. Schematic representation of the type III secreton of Shigella in the context of bacterial interaction with epithelial cells and macrophages. Beside the type III secreton and its cognate target proteins, other important proteins are encoded by the virulence plasmid. Among these, SepA is a secreted serine protease whose function has not yet been established [17]. The most important, however, is IcsA (VirG), which achieves the actin-based motility of Shigella and permits its passage from one cell to another [18]. IcsA (VirG) is a 120-kDa surface protein which localizes at one pole of the bacterial body and is able to cause actin-dependent motility. Actin-based motility, in the context of a polarized epithelium establishing intercellular junctions, allows cell-to-cell spread in a process that involves the engagement of components of the cellular junction by the pathogen in order to form a protrusion which is internalized by the neighboring cell. Lysis of the protruding membranes allows escape of the bacterium into the cytoplasm of the newly infected cell and so on, establishing a remarkably efficient system allowing extended cellular colonization. IcsA mutants are severely impaired in pathogenicity, including in monkeys and even in human volunteers as recently tested. Shigella is an interesting paradigm of co-evolution and mutual adaptation between plasmid and chromosomal virulence genes. Beside the core of virulence plasmid genes that dictate the direct interaction of bacteria with the various cell populations that make up the epithelial barrier, chromosomal genes also participate in the pathogenic process. This was strongly suggested by classical recombination experiments showing that introduction of the S. flexneri virulence plasmid into Escherichia coli K12 conferred full invasiveness on the transconjugants in in vitro systems whereas successive conjugative transfer of various of the in conferred full virulence in in of infection These chromosomal genes can be into two genes that regulate the expression of the virulence genes on the plasmid. This category is by a a to which controls the expression of and proteins genes that are important for bacterial in the intestinal and in infected such as those the and several of them being on identified In addition, in S. is encoded by a chromosomal should also the of in the Shigella to of which expression of the full invasive phenotype of of the sequence of isolates of S. S. 1 and S. sonnei should our understanding of the events that have to of Shigella as a on a with the coli the initial of the entry process, Shigella induces actin polymerization at the of bacterial contact with the host cell membrane polymerization that to This results in a macropinocytic which the of this is the of a series of maturation that are by the effector proteins and and are essential of cellular cytoskeletal These proteins are in their formation of from the cellular formation of and which does not induce actin to formation and of cell adherence The three are in the formation of the cellular that formation of the Shigella entry for the sequence of events that is as into the eukaryotic cell as a of the complex that a the C-terminal domain of IpaC which is on the cytoplasmic actin [16] by inducing activation of and The through a protein of the and the actin This activation is likely to account for the of followed by The mechanisms in the activation of by IpaC are a protein in the host cell in the of bacterial entry IpaC does not an in vitro activity on those At the activation of appears to be a major of actin to from the cell surface. This is to two major The and engagement of the which expresses two major It an protein that is at the of the and to be in actin It also by inducing of a that actin polymerization The of a like induces of It however, that inducing massive cytoskeletal Shigella does not a fully entry focus. from the cell surface even tend to the bacterial body A of maturation is required that involves injection of IpaA into the host cell that not express IpaA enter epithelial cells with their whereas they induce entry that are not only as as those induced by the but also and induced by mutants massive and actin but to form an or the endocytic vacuole. This structure results from the of actin indicating that the presence of IpaA induces actin and its of this maturation process results from the of IpaA to the of a protein which the formation of cell adherence of IpaA to the with a in the 5 the form of and induces its a that participates in the process in its C-terminal and a for in its In addition, this interaction also results in actin This is another of a bacterial protein of cell via its with activity to a protein target. The mechanisms that the of these maturation events The of the that induce and the macropinocytic Shigella are summarized in Fig. Schematic representation of the causing and maturation of the cytoskeletal that to formation of the macropinocytic Shigella into epithelial cells. After lysis of the vacuole, Shigella and an at one of its This process a which allows the bacterium to and spread from cell to cell [18]. The of Shigella to via an actin-dependent is a with and the actin-based motility is by a outer membrane This protein is and by its C-terminal domain into the bacterial outer The which is by the presence of the of the protein required to induce actin IcsA a on the bacterial cell surface that is essential for of the and straight the cell cytoplasm IcsA is unable to induce actin and it was considered that this protein was able to one or several allowing this process to Although was to play a role that the of is a of the of of actin via the of a complex between and is necessary and sufficient to cause actin in the presence of actin The interaction between IcsA and involves the and to These to actin and polymerization are summarized in Fig. that in to this proteins the process of actin such as the protein and are necessary to bacterial motility mechanisms of actin which Shigella motility in the cytoplasmic A major of the Shigella invasive phenotype is the capacity to spread from one cell to spread is a direct of the actin-based motility process. In the context of a polarized as can be in vitro by human colonic cell such as and bacteria the components of the adherence the and form a protrusion which is by the neighboring cell in a process activation of the indicating a role for the that a process of the protrusion is Escape from the two membranes expression of IpaB and IpaC in the cytoplasm of the adjacent cells, bacteria can to the cell and so This of Shigella infection in the context of a polarized epithelium is summarized in Fig. Schematic representation of the of interaction between Shigella and epithelial cells that the invasive Shigellosis is a paradigm of a pathogen innate essentially to and invade the intestinal in an to the invasive inflammation and causes major tissue destruction that the of the and observed in the of before this Shigella the epithelial barrier, a process that is with through the pole of epithelial cells. that the initial entry is the epithelium that the cells a of the epithelial cells of the in other the epithelial that the associated with the intestinal mucosa, in in the or as in the colon and These in the of intestinal cells and on their surface. Their is to and microorganisms from the intestinal The activity of cells of and through the epithelial barrier, straight into the of mucosal immunity cells form a with and macrophages, direct contact between the intestinal and the mucosal Although the entire surface of is about of that of the epithelial it a role in the of the mucosal barrier and at the is used by to the epithelial barrier since it this the to the intestinal invade epithelial cells through their or between cells by their this the to an by the presence of macrophages, particularly in the of the (i.e. the between and the In this an invasive pathogen develop allowing its to the killing mechanisms of cells. of that the major enteroinvasive Shigella, and primarily the as their entry These have to survive their with phagocytes. Shigella has for a by the apoptotic killing of macrophages, escape in and invasion of the epithelial although able to also induce macrophage has a of its intracellular and of genes allowing its intracellular It is that a established between the and their bacterial allows systemic dissemination the of these phagocytes. is also able to cause macrophage death. it that the of its interaction is the expression of a which causes to essentially in infected The that cells of the are the major of initial epithelial for Shigella was on a of experiments in the intestinal of as well as in a of after their bacteria are in and in cells. that many of these infected cells major indicating their death. In vitro also that in the presence of virulent quickly The killing process was identified as It of invasive and is caused by IpaB IpaB causes apoptosis of macrophage in to entry into epithelial cells, another major of the Shigella invasive In vivo, massive of apoptosis is of infected by an invasive Shigella of these cells are and also cells which are also by invasive in vitro and in but and cells are also that direct infection of cells is not an for apoptosis in the of Shigella This apoptosis caused by invasive Shigella is not only likely to bacterial of the epithelial but is also central to early triggering of inflammation. This dual function the molecular mechanisms of IpaB triggering of the macrophage program induced by invasive IpaB to for This activation of this protease into its components which thereby a capacity to the and but also to the apoptotic program of the cell, 1 being able to cause cell its to the cell of The that 1 has been as a target by IpaB accounts for the dual function that cell and release of and IL-18, two pro-inflammatory The of which 1 against Shigella killing of and from 1 are to apoptotic killing by Shigella, that 1 is central to the process Although other cell populations are likely to express 1 or it is not yet Shigella remains to the and cell The effect of the increased secretion of may be by the associated release of to the massive cell by In addition, the effect of the of in the infected may be even by the of observed during the early of of is a of which to the but has no function, as a of inflammation in the presence of of in infection of intestinal by Shigella has a thereby the of tissue It also the of bacterial that Shigella uses of the epithelial barrier to its invasive capacity in a of infection causing acute followed by have it to the role of 1 in the of the innate to A of in a series of (i.e. that caused tissue destruction that bacterial whereas was in the of bacterial to its effect on which appears to be essential in the against It is likely that macrophage apoptosis early after bacteria have the caused inflammation in the inflammatory of the epithelial barrier and of bacterial dissemination and of Shigella The is now well that in to bacterial colonic epithelial cells express a large of pro-inflammatory particularly such as of epithelial cells by Shigella the of which accounts for the of by intracellular accounts for the and activation of [5]. This is likely to inflammation by more PMNs to the In the intestinal of of causes a effect on the of the infectious process with a major in the of PMNs into the and invading the This that a major function of by epithelial cells is to PMNs to areas where bacterial invasion of the epithelium is of the function of causes a in the severity of epithelial but allows passage of the bacteria in the In the surface of Shigella infection by PMNs an at the of epithelial such a inflammation at the early of infection like an for a bacterium which primarily at its killing by the innate killing of may not for the effect from the of PMNs that to inflammatory of during infection of intestinal tissue has shown that not only was inflammation and tissue destruction but also the of bacteria invading those In addition, injection of a against which to also controls the inflammatory destruction of and the of invading bacteria It was then to a process of in vitro in which are able to of basal the of the epithelial and allowing quick invasion of epithelial cells. It is likely that the spread of bacterial at a from the is by a of PMNs which the epithelial allowing bacterial entry into the epithelial cells, bacteria and spread from cell to cell, efficient intracellular in a In the of the colonic and rectal mucosa as allowing of the intestinal epithelial barrier and early of the inflammatory during the process of macrophage death. of infection from these to of the epithelium may via a of inflammation and invasion for bacteria which are at invading the epithelial barrier This in which inflammation and invasion their the severity of the inflammatory destruction which is of the disease. The of rupture, invasion and destruction of the intestinal barrier by Shigella are summarized in Fig. Schematic representation of the and that to through the epithelial barrier, invasion and inflammatory destruction of the intestinal mucosa by on the of the process, although it is still to these to be essential to the of early of infection as recently in a of infection In this for the to be five of more susceptible to Shigella infection the In addition, and of increasing severity to the with bacterial cells may be the major of in this This is in the context of the situation since of has been during the early of Shigella infection in This which remains to be in molecular and cellular may early of Shigella in PMNs are likely to play a major role in the of Shigella early of PMNs epithelial thereby invasion by the to epithelial colonization. not escape the in these cells. in a vacuole, in spite of the expression of their invasive bacteria may killing by and by proteins such as the increasing protein [8]. that of a pattern which participates in the cells in the presence of of Shigella in mucosal This is a that during the infectious process, by is used as a signal that the It is that the to be to the understanding of how the innate system Shigella infection and how this affects the and progress in the understanding of how the system bacterial at the of primary infection and prevents infection in people should in developing vaccine candidates against this disease. The like to express to and all the and of the as well as to our at the and for their to the understanding of the of shigellosis.
Author: P Sansonetti
Language: English
Subfield: Microbiology
Open Access status: bronze
OpenAlex ID: W1989510697
FWCI: 2.472
Cites: 66
Cited by: 199
Related to: 10